HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

9-(dimethylaminoethoxy)ellipticine

modulates MYC expression; has potential as an antineoplastic agent for the treatment of multiple myeloma; structure in first source
Also Known As:
EPED3 cpd; GQC-05; NSC 338258; NSC-338258; NSC338258
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Gokhale, Vijay: 2 articles (12/2019 - 11/2011)
2. Hurley, Laurence H: 2 articles (12/2019 - 11/2011)
3. Arceci, Robert J: 1 article (12/2019)
4. Azorsa, David O: 1 article (12/2019)
5. Lee, David W: 1 article (12/2019)
6. Montoya, Justin J: 1 article (12/2019)
7. Patel, Apurvi R: 1 article (12/2019)
8. Turnidge, Megan A: 1 article (12/2019)
9. Wai, Daniel H: 1 article (12/2019)
10. Wetmore, Cynthia: 1 article (12/2019)

Related Diseases

1. Burkitt Lymphoma (Burkitt's Lymphoma)
2. Multiple Myeloma

Related Drugs and Biologics

1. DNA (Deoxyribonucleic Acid)
2. Antineoplastic Agents (Antineoplastics)
3. ellipticine